This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Pediatric Heart Transplant Recipients, Pediatric Cardiac Transplantation or Pediatric Heart Transplantation
and you are
between 11 and 17
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to collect and compare information on how and when adolescent heart transplant recipients take their prescribed medication. The investigators want to find out if regular use of 'an app' on cell phones, called the Teen Pocket PATH® (TPP), can help adolescents take their medication according to their prescribed dosing schedule. This may then help reduce complications of transplant, such as rejection. The investigators also want to find out if how adolescent heart transplant recipients take their medications affects the development of antibodies in their blood. Antibodies are small proteins in the blood that may develop after heart transplantation, and which can sometimes damage a new heart.

Provided treatments

  • Other: Teen Pocket PATH® Mobile Application
  • Other: Control Group: Standard of Care

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02904278. The sponsor of the trial is National Institute of Allergy and Infectious Diseases (NIAID) and it is looking for 26 volunteers for the current phase.
Official trial title:
Randomized, Controlled Trial of a Novel Mobile Device Application to Improve Adherence in Children Greater Than 11 Years of Age After Cardiac Transplantation (CTOTC-10)